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Abstract
Background: Internal jugular vein thrombosis is a rare vascular event with a potentially fatal outcome. Of the
known etiologies, internal malignancies, either known or occult, are well described. Even though malignancies are
known to present with internal jugular vein thrombosis, it rarely occurs due to prostate carcinoma. Many cases of
jugular vein and superior vena cava thrombosis secondary to malignancies are due to metastatic compression of
veins. Recurrent and unusual vascular thrombosis due to hypercoagulability associated with malignancies is also
known as Trousseau’s syndrome. Here we report a rare case of a patient with internal jugular vein thrombosis as a
presenting feature of metastatic prostate carcinoma, which is a case of Trousseau’s syndrome.
Case presentation: A 75-year-old Sri Lankan man with hypertension, hyperlipidemia, and past history of
spontaneous intracranial hemorrhage presented with a short history of painless swelling in his left supraclavicular
fossa. An examination revealed the swelling was due to a thickened left external jugular vein. A duplex ultrasound
scan revealed left-sided internal jugular, external jugular, and brachiocephalic venous thrombosis. Surveillance into
underlying malignancies showed an irregular, hard prostate gland suspicious of prostate carcinoma, which was
proven with histology, and biochemically. A computed tomography scan found extensive vertebral, pelvic bone,
intra-abdominal lymph node metastasis, and a single right-sided lower lung metastatic lesion, with no direct
involvement of the jugular vein.
Conclusions: Spontaneous thrombosis of the internal jugular vein due to Trousseau’s syndrome is rare and
unusual. Clinicians should promptly investigate for malignancies as it can be the first presentation of underlying
occult malignancies. Although prostate carcinomas are rare to present with internal jugular vein thrombosis, this
case illustrates the importance of having a high degree of suspicion in the appropriate clinical setting.
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Background
Internal jugular venous thrombosis is a rare vascular
event that occurs secondary to prolonged central venous
catheterization, intravenous drug abuse, head and neck
infections, trauma, and hypercoagulable status [1–3].
Rarely, spontaneous internal jugular vein thrombosis can
be the presenting feature of underlying malignancy,
known or occult [4]. Suggested mechanisms are (1)
direct effect by the metastatic tumor, (2) as a result
of hypercoagulable status and migratory thrombophebitis,
generated secondary to the underlying malignancy, known
as Trousseau’s syndrome. Even though internal jugular
venous and superior vena cava thromboses have been
reported in association with prostate carcinoma, many of
them are due to the mechanical effects of metastatic
tumors. However, we report the case of a patient with
spontaneous internal jugular venous thrombosis extend-
ing to the external jugular and brachiocephalic veins, as a
result of Trousseau’s syndrome, as a presenting feature of
metastatic prostate carcinoma.
Case presentation
A 75-year-old Sri Lankan man with past history of
hypertension and hyperlipidemia of 6-year duration and
spontaneous right parietal intracranial hemorrhage 6
years ago with near normal recovery presented with
painless swelling in his left supraclavicular area for the
past 10 days. There had been no trauma or interventions
done involving his neck and upper limb in the recent
past. He did not have a history suggestive of ear, nose,
throat, or oral infections and denied dyspnea, hemoptysis,
back pain, lower urinary tract symptoms, or constitutional
symptoms.
An examination revealed a nontender swelling in his
left supraclavicular fossa due to a cord-like thickening of
the left external jugular vein. There were no signs of in-
fection either locally or involving his left upper limb. An
examination of his oral cavity, ear, nose, and throat was
unremarkable, and there was no lymphadenopathy. His
upper limbs and face did not show evidence of venous
congestion. Examinations of his cardiovascular, respira-
tory, central nervous, musculoskeletal and abdominal
system were normal, but a digital examination of his
rectum revealed a moderately enlarged, hard, irregular
prostate gland.
A venous duplex ultrasound scan of his neck con-
firmed thrombosis of his left internal jugular, extending
into his external jugular and brachiocephalic veins
(Fig. 1). A contrast-enhanced computed tomography
(CT) scan of his neck and upper chest demonstrated pa-
tent superior vena cava and right jugular veins, but his
left internal jugular, external jugular, and left brachioce-
phalic veins were not visualized. However, it was unable
to show thrombosis of these nonvisualized veins, as the
study was done in the arterial phase. A chest radiograph
did not show any masses or mediastinal widening.
His hematological investigations showed a hemoglobin
of 11.4 g/dL, a white cell count of 8170/ mm3
Fig. 1 Ultrasound duplex scan of neck showing thrombosis of internal jugular vein. EXT JUG V external jugular vein, INT JUG V internal jugular vein
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(neutrophil 66 %, lymphocyte 21 %, middle fraction 13 %)
and a platelet count of 530,000/mm3. The blood picture
revealed evidence of inflammation. His erythrocyte sedi-
mentation rate was 40 mm in the first hour (normal <20).
His C-reactive protein level was 3 mg/l (normal <10 mg/L).
A blood culture revealed no growth at 48 hours. Co-
agulation studies with activated partial thromboplastin
time (APTT) and prothrombin time (PT) were normal.
Thrombophilia screening was normal (antinuclear anti-
bodies, anticardiolipin antibodies were not detected).
His renal functions were normal, but liver tests revealed
alkaline phosphatase (ALP) of 215 IU/L (53–128 IU/L)
and gamma-glutamyltransferase (GGT) of 222 IU/L
(normal <31 IU/L), while other enzymes were within
normal range. His serum calcium was significantly
elevated to 3.9 mmol/l. Human immunodeficiency virus
(HIV) antibodies and venereal disease research laboratory
(VDRL) test results were negative.
His prostate-specific antigen was greatly elevated to
257 ng/ml (normal <4 ng/ml). An ultrasound scan of his
pelvis revealed a heterogeneously enlarged prostate with
central calcification. A prostate biopsy revealed 30 % of
tissue infiltrated by a conventional prostate adenocarcin-
oma of acinar type, which is predominantly composed of
small glandular structures arranged in ill-defined nod-
ules, giving the primary Gleason morphologic grade of 3,
and less commonly of cribriform structures and large ir-
regular glands, giving the secondary pattern as Gleason
morphology grade 4. Perineural invasion, lymphovascu-
lar emboli or extraprostatic tissue infiltration was not
demonstrated in the sections examined (Fig. 2). There
was a single lung metastasis in the lower lobe of his right
lung, but no pleural effusion. There was no evidence of
cervical or mediastinal metastasis.
He was immediately started on anticoagulation therapy
with intravenous heparin followed by oral warfarin, to
maintain his international normalized ratio (INR) 2–3.
He showed a good response with treatment resulting in
symptomatic relief and resolved neck swelling. He did
not develop further thrombotic episodes while on antic-
oagulation therapy. He is currently being treated at the
oncology unit with a chemotherapeutic regimen, which
includes docetaxel and bicalutamide.
Discussion
Internal jugular venous thrombosis was first described
by Long as a complication of peritonsillar abscess in
1912 [5]. It is a rare, but potentially fatal vascular event
[1]. Central venous catheterization is the commonest eti-
ology in modern clinical practice [4]. A review done by
Shakeel et al. illustrated many other causes including
deep head and neck infections, intravenous drug abuse,
hypercoagulable disorders, ovarian hyperstimulation,
and malignancies [6].
Central venous thrombosis in association with malig-
nancies may occur as result of (1) local disturbance to
venous flow due to malignancy itself or metastatic
deposits, or (2) due to hypercoagulability associated with
malignancies. Migratory thrombophebititis due to dis-
tant malignancies, known as Trousseau’s syndrome can
cause thrombosis in unusual sites including internal
jugular veins and superior vena cava [7]. Several factors
are responsible for hypercoagulability in malignancies.
These include (1) increased procoagulant factors (for
example, tissue factor, cancer procoagulant), (2) reduced
anticoagulant factors (for example, antithrombin, protein
C, protein S, tissue factor pathway inhibitor), (3) altered
fibrinolysis through elevated plasminogen activator inhibi-
tor, (4) expression of tissue factor and cytokines, which
activate coagulation cascade, (for example, tumor necrosis
factor, interleukin 1 and 6) [8]. Sack et al. reviewed 541
patients with Trousseau’s syndrome and reported that
underlying malignancy was found in lung (25.6 %), pan-
creas (17.4 %), stomach (16.8 %), colon (15.2 %), prostate
(6.5 %), and others [9].
Prostate carcinoma has been shown to cause internal
jugular venous or superior vena cava thrombosis in few
case reports. [7, 10–13]. Except for the case report
published by Takeda et al. [7] where superior vena
cava thrombosis had occurred as a nonmetastatic
manifestation, all the other cases had venous thrombosis
in association with mediastinal metastasis of prostate car-
cinoma. As there was no cervical or mediastinal metasta-
sis in our patient, internal jugular thrombosis in this case
is likely to be due to hypercoagulability and Trousseau’s
syndrome secondary to distant prostate carcinoma. Be-
cause large central veins are valveless and they have an
elastic wall, allowing alternative collapse and expansion by
the action of respiration and heart pumping, Trousseau’s
syndrome in head and neck veins is rare [14], making our
case an unusual presentation of prostate carcinoma.
Fig. 2 Histology of prostate adenocarcinoma showing an abnormal
gland with a irregular, thick wall, made up of cells with abnormally
large nuclei (arrow)
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Contrast venography is the gold standard investigation
for diagnosis of internal jugular vein thrombosis. But du-
plex ultrasound provides a more cost-effective, portable,
easily available diagnostic method with excellent accur-
acy, without radiation [4]. However, ultrasonography
lacks the ability to provide detailed information regard-
ing the surrounding tissue and often needs to be
followed by CT and magnetic resonance imaging (MRI),
which provide valuable information for identifying the
underlying pathology [6].
Treatment of internal jugular venous thrombosis is
anticoagulation therapy, initially with intravenous hep-
arin followed by long-term anticoagulation therapy with
oral warfarin. However, the definitive treatment should
involve treatment of the underlying malignancy [2].
Conclusions
Spontaneous thrombosis of the internal jugular vein is
extremely rare and an unusual presentation. Prompt
diagnosis and treatment is necessary to prevent serious
complications. Patients should be investigated for malig-
nancies as it can be the first presentation of underlying
distant malignancies. Although prostate carcinomas are
rare to present as internal jugular vein thrombosis due to
Trousseau’s syndrome, this case emphasizes the import-
ance of awareness among physicians regarding rare pre-
sentations of internal malignancies for correct diagnosis
and appropriate management.
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